GAITHERSBURG, Md., Nov. 17 /PRNewswire/ -- MedImmune today announced
winners of a research abstract competition highlighting the work of tomorrow's
potential scientific leaders in respiratory disease, inflammation and
autoimmunity. Last Friday, MedImmune convened the competition's 10 finalists
to present their research to an expert panel of MedImmune judges in the Third
Annual Research Abstract Competition at the company's headquarters facility in
"One of our primary objectives at MedImmune is to promote and advance
health and science education, and this competition allows us to do that for
researchers pursuing advanced degrees in the therapeutic areas of respiratory
disease, inflammation and autoimmunity," said Anthony J. Coyle, Ph.D., vice
president, research and development and head, inflammation and autoimmunity
research. "It is encouraging to see the high caliber of scientific research
that went into the submissions we received. The students represented here
embody the future of science leadership, and we at MedImmune are honored to
play a part in their careers by providing some recognition for their hard
The competition was open to graduate students and postdoctoral fellows in
the United States and around the world. The team of MedImmune judges evaluated
the abstracts according to the following criteria: Ethics, suitability of
methods to aims, conclusions confirmed by objective results, scientific value,
potential clinical value, originality of work and overall presentation.
The following three winners were selected based on scientific merit,
presentation content and delivery:
First Place: University of North Carolina at Chapel Hill Postdoctoral
Student Irving Allen. The title of his abstract is, "The NLRP3 Inflammasome is
Essential for the Regulation of Innate Responses to Influenza A Virus
Second Place: Harvard University Postdoctoral Student Anneli Jaeger. The
title of her abstract is, "Tracking of TH17 Cells & New Populations of
IL-17-Expressing Cells with IL-23 Receptor (IL-23R) GFP Reporter Mice."
Third Place: National Institutes of Health National Cancer Institute
Postdoctoral Student Karen Muindi. The title of her abstract is, "Cellular
Lipids & Immunity: Characterization of Glycolipids Binding the Antigen
Presenting Molecule CD1."
"I would like to thank everyone at MedImmune for sponsoring this
competition," said Irving Allen, first place winner and a student at the
University of North Carolina at Chapel Hill. "It has been a great experience
for me and I am hopeful that this research will ultimately yield therapies to
treat a variety of human diseases."
MedImmune is a leading innovation-focused biotechnology company whose
mission is to provide better medicines to patients, new medical options for
physicians and rewarding careers to employees. Dedicated to advancing science
and medicine to help people live better lives, the company is focused on
infection, oncology, respiratory disease and inflammation, cardiovascular/
gastrointestinal disease and neuroscience. Headquartered in Gaithersburg,
Maryland, MedImmune has approximately 3,000 employees worldwide and is the
wholly owned biologics business for AstraZeneca plc (LSE: AZN.L, NYSE: AZN).
For more information, visit MedImmune's website at www.medimmune.com.
CONTACT: Sidoney Atse of MedImmune, +1-301-398-5990